Paper Details

  1. Home
  2. Paper Details

Incidence of ethambutol-related visual impairment during treatment of active tuberculosis.

Author: BenedettiA, Darvish-ZargarM, EzerN, MenziesD

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

New guidelines recommend adding ethambutol (EMB) to tuberculosis (TB) treatment in areas with high isoniazid resistance, potentially reducing multidrug resistance. However, EMB can cause vision problems.
Paper Details　
Original Abstract of the Article :
Recent World Health Organization guidelines recommend the addition of ethambutol (EMB) throughout standardised treatment of new cases of active tuberculosis (TB) in populations with increased prevalence of isoniazid resistance to reduce the risk of creating multidrug resistance. This could expose pa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.5588/ijtld.11.0766

データ提供：米国国立医学図書館（NLM）

Navigating the Risks of Ethambutol: A Crucial Consideration in Tuberculosis Treatment

Infectious diseases are a constant challenge, and this study focuses on the treatment of tuberculosis (TB). The authors explore the use of ethambutol (EMB) in the treatment of TB, a drug that can cause visual impairment. They discuss the potential risks and benefits of using EMB in the context of new World Health Organization (WHO) guidelines recommending its inclusion in standardized TB treatment.

The Balancing Act of TB Treatment

The WHO's recommendation to include EMB in TB treatment is based on its effectiveness in preventing multidrug resistance. However, the study highlights the potential risk of EMB-related visual impairment. This poses a dilemma for clinicians, balancing the benefits of preventing multidrug resistance with the risk of visual impairment. It's like navigating a desert - the path to safety might involve some challenges and obstacles.

A Call for Vigilance

This study underscores the importance of careful monitoring and early detection of any potential visual impairment in patients receiving EMB treatment. It highlights the need for a tailored approach to TB treatment, considering individual risk factors and potential complications. Remember, the desert is full of hidden dangers, but with vigilance and careful planning, we can navigate its treacherous terrain safely.

Dr. Camel's Conclusion

This study reminds us that the treatment of infectious diseases can be a delicate dance, balancing risks and benefits. The use of EMB in TB treatment is a prime example of this complexity. It emphasizes the need for careful monitoring and a personalized approach to ensure optimal patient outcomes. Just as we navigate a desert, it's crucial to be aware of the potential hazards and have a plan in place to address them.

Date :
  1. Date Completed 2013-08-30
  2. Date Revised 2023-06-12
Further Info :

Pubmed ID

23394767

DOI: Digital Object Identifier

10.5588/ijtld.11.0766

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.